These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16241869)

  • 1. Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.
    La Flamme KE; Mor G; Gong D; La Tempa T; Fusaro VA; Grimes CA; Desai TA
    Diabetes Technol Ther; 2005 Oct; 7(5):684-94. PubMed ID: 16241869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cell density and device arrangement on the behavior of macroencapsulated beta-cells.
    La Flamme KE; LaTempa TJ; Grimes CA; Desai TA
    Cell Transplant; 2007; 16(8):765-74. PubMed ID: 18087997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations.
    Leoni L; Desai TA
    IEEE Trans Biomed Eng; 2001 Nov; 48(11):1335-41. PubMed ID: 11686632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of nanoporous alumina membranes for immunoisolation.
    La Flamme KE; Popat KC; Leoni L; Markiewicz E; La Tempa TJ; Roman BB; Grimes CA; Desai TA
    Biomaterials; 2007 Jun; 28(16):2638-45. PubMed ID: 17335895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material.
    Cheng SY; Gross J; Sambanis A
    Biotechnol Bioeng; 2004 Sep; 87(7):863-73. PubMed ID: 15334413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micromachined biocapsules for cell-based sensing and delivery.
    Leoni L; Desai TA
    Adv Drug Deliv Rev; 2004 Feb; 56(2):211-29. PubMed ID: 14741117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anodic aluminium oxide membranes for immunoisolation with sufficient oxygen supply for pancreatic islets.
    Cho S; Lee S; Jeong SH; Kim Y; Kim SC; Hwang W; Park J
    Integr Biol (Camb); 2013 May; 5(5):828-34. PubMed ID: 23546334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfabrication technology for pancreatic cell encapsulation.
    Desai TA
    Expert Opin Biol Ther; 2002 Aug; 2(6):633-46. PubMed ID: 12171507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-supporting nanoporous alumina membranes as substrates for hepatic cell cultures.
    Hoess A; Thormann A; Friedmann A; Heilmann A
    J Biomed Mater Res A; 2012 Sep; 100(9):2230-8. PubMed ID: 22492687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of asymmetric poly(vinyl alcohol) membranes for use in artificial islets.
    Young TH; Yao NK; Chang RF; Chen LW
    Biomaterials; 1996 Nov; 17(22):2139-45. PubMed ID: 8922599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of alginate encapsulation on NIT-1 insulinoma cells: viability, growth and insulin secretion.
    Bertolotti A; Borgogna M; Facoetti A; Marsich E; Nano R
    In Vivo; 2009; 23(6):929-35. PubMed ID: 20023235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An encapsulation system for the immunoisolation of pancreatic islets.
    Wang T; Lacík I; Brissová M; Anilkumar AV; Prokop A; Hunkeler D; Green R; Shahrokhi K; Powers AC
    Nat Biotechnol; 1997 Apr; 15(4):358-62. PubMed ID: 9094138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: Implications of low molecular weight cut-off.
    Risbud MV; Bhargava S; Bhonde RR
    J Biomed Mater Res A; 2003 Jul; 66(1):86-92. PubMed ID: 12833434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.
    Shao S; Gao Y; Xie B; Xie F; Lim SK; Li G
    J Endocrinol; 2011 Mar; 208(3):245-55. PubMed ID: 21212095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of glucose-responsive material to regulate insulin release from constitutively secreting cells.
    Cheng SY; Constantinidis I; Sambanis A
    Biotechnol Bioeng; 2006 Apr; 93(6):1079-88. PubMed ID: 16440350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nanoporous, transparent microcontainer for encapsulated islet therapy.
    Gimi B; Kwon J; Kuznetsov A; Vachha B; Magin RL; Philipson LH; Lee JB
    J Diabetes Sci Technol; 2009 Mar; 3(2):297-303. PubMed ID: 19746206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodritin microencapsulated human islets of Langerhans and their potential for type 1 diabetes mellitus therapy.
    Campos-Lisbôa AC; Mares-Guia TR; Grazioli G; Goldberg AC; Sogayar MC
    Transplant Proc; 2008 Mar; 40(2):433-5. PubMed ID: 18374092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas.
    Sambanis A; Papas KK; Flanders PC; Long RC; Kang H; Constantinidis I
    Cytotechnology; 1994; 15(1-3):351-63. PubMed ID: 7765950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polyethylene oxide-functionalized self-organized alumina nanochannel array for an immunoprotection biofilter.
    Lee S; Park M; Park HS; Kim Y; Cho S; Cho JH; Park J; Hwang W
    Lab Chip; 2011 Mar; 11(6):1049-53. PubMed ID: 21283907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of insulin secretion from MIN6 pseudoislets after encapsulation in a prototype device of a bioartificial pancreas.
    Barrientos R; Baltrusch S; Sigrist S; Legeay G; Belcourt A; Lenzen S
    Horm Metab Res; 2009 Jan; 41(1):5-9. PubMed ID: 18855306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.